Hosseini Shabanan Sedighe, Seyedmirzaei Homa, Barnea Alona, Hanaei Sara, Rezaei Nima
School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Cell Tissue Res. 2022 Feb;387(2):177-205. doi: 10.1007/s00441-021-03551-3. Epub 2022 Jan 10.
Retinal degenerative diseases such as retinitis pigmentosa (RP) are of the major causes of vision loss in developed countries. Despite the unclear pathophysiology, treatment methods have been investigated vastly in the past decades. This review article mainly discusses the advances in application of stem cell and progenitor transplantation for retinitis pigmentosa. Stem cell sources such as mesenchymal stem cells, embryonic stem cells, induced pluripotent stem cells, neural stem cells, retinal progenitor cells, and olfactory ensheathing cells are discussed separately in addition to a brief description of two approaches for treatment of early-stage RP, including gene therapy and nutritional therapy.
视网膜色素变性(RP)等视网膜退行性疾病是发达国家视力丧失的主要原因之一。尽管其病理生理学尚不清楚,但在过去几十年中对治疗方法进行了大量研究。这篇综述文章主要讨论了干细胞和祖细胞移植在视网膜色素变性治疗中的应用进展。除了简要介绍治疗早期RP的两种方法(基因治疗和营养治疗)外,还分别讨论了间充质干细胞、胚胎干细胞、诱导多能干细胞、神经干细胞、视网膜祖细胞和嗅鞘细胞等干细胞来源。